DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Esidrix (Hydrochlorothiazide) - Cerebral Hypoperfusion - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Cerebral Hypoperfusion (8)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Esidrix (Hydrochlorothiazide) where reactions include cerebral hypoperfusion. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Esidrix side effects in female

Reported by a physician from France on 2012-07-26

Patient: female

Reactions: Cerebral Hypoperfusion, Bradycardia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Levothyroxine Sodium
    Administration route: Oral
    Indication: Hypothyroidism

Nexium
    Administration route: Oral

Esidrix
    Administration route: Oral
    Indication: Cardiac Failure

Lasix
    Administration route: Oral
    Indication: Cardiac Failure

Digoxin
    Administration route: Oral
    Indication: Atrial Fibrillation
    End date: 2012-04-17

Sintrom
    Dosage: 0.25 df 3 days out of 4
    Administration route: Oral
    Indication: Atrial Fibrillation

Lyrica
    Administration route: Oral



Possible Esidrix side effects in 87 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-25

Patient: 87 year old female

Reactions: Cerebral Hypoperfusion, Bradycardia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lasix
    Dosage: long-term therapy.
    Administration route: Oral

Nexium
    Dosage: long-term therapy.
    Administration route: Oral

Sintrom
    Dosage: long-term therapy. dose:0.25 unit(s)
    Administration route: Oral
    Indication: Atrial Fibrillation

Levothyroxine Sodium
    Dosage: long-term therapy.
    Administration route: Oral
    Indication: Hypothyroidism

Digoxin
    Dosage: long-term therapy.
    Administration route: Oral
    Indication: Atrial Fibrillation
    End date: 2012-04-17

Lyrica
    Dosage: long-term therapy.
    Administration route: Oral

Esidrix
    Dosage: long-term therapy.
    Administration route: Oral



Possible Esidrix side effects in male

Reported by a physician from Canada on 2012-06-06

Patient: male, weighing 61.8 kg (136.0 pounds)

Reactions: Cerebral Hypoperfusion, Hypotension

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Blinded Aliskiren
    Dosage: active run in phase
    Indication: Cardiovascular Disorder

Blinded NO Treatment Received
    Dosage: active run in phase
    Indication: Cardiovascular Disorder

Placebo
    Dosage: active run in phase
    Indication: Cardiovascular Disorder

Esidrix
    Dosage: active run in phase
    Indication: Cardiovascular Disorder

Hydrochlorothiazide
    Dosage: 25 mg, unk
    End date: 2011-11-09

Aliskiren
    Dosage: 150 mg, unk
    Indication: Cardiovascular Disorder
    Start date: 2011-10-01
    End date: 2011-11-09

Amlodipine
    Dosage: 5 mg, unk
    Indication: Cardiovascular Disorder
    Start date: 2011-10-01
    End date: 2011-10-08

Amlodipine
    Dosage: active run in phase
    Indication: Cardiovascular Disorder

Valsartan
    Dosage: 160 mg, qd

Other drugs received by patient: Angiotensin II Antagonists; Aspirin; Atorvastatin Calcium



Possible Esidrix side effects in 87 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-18

Patient: 87 year old female

Reactions: Cerebral Hypoperfusion, Bradycardia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Digoxin
    Dosage: 1 df, 1x/day
    Administration route: Oral
    Indication: Atrial Fibrillation
    End date: 2012-04-17

Nexium
    Dosage: 20 mg, 1x/day
    Administration route: Oral

Esidrix
    Dosage: 25 mg, 1x/day
    Administration route: Oral
    Indication: Cardiac Failure

Levothyroxine Sodium
    Dosage: 50 ug, 1x/day
    Administration route: Oral
    Indication: Hypothyroidism

Lyrica
    Dosage: 50 mg, 1x/day
    Administration route: Oral

Lasix
    Dosage: 40 mg, 1x/day
    Administration route: Oral
    Indication: Cardiac Failure

Sintrom
    Dosage: 0.25 df, 3 days out of 4
    Administration route: Oral
    Indication: Atrial Fibrillation



Possible Esidrix side effects in female

Reported by a physician from France on 2012-05-18

Patient: female

Reactions: Cerebral Hypoperfusion, Bradycardia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Digoxin
    Administration route: Oral
    Indication: Atrial Fibrillation
    End date: 2012-04-17

Lyrica
    Administration route: Oral

Nexium
    Administration route: Oral

Esidrix
    Administration route: Oral
    Indication: Cardiac Failure

Sintrom
    Dosage: 0.25 df 3 days out of 4
    Administration route: Oral
    Indication: Atrial Fibrillation

Levothyroxine Sodium
    Administration route: Oral
    Indication: Hypothyroidism

Lasix
    Administration route: Oral
    Indication: Cardiac Failure



Possible Esidrix side effects in 87 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-16

Patient: 87 year old female

Reactions: Cerebral Hypoperfusion, Depressed Level of Consciousness, Bradycardia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Digoxin
    Administration route: Oral
    Indication: Atrial Fibrillation
    End date: 2012-04-17

Lyrica
    Administration route: Oral

Levothyroxine Sodium
    Administration route: Oral
    Indication: Hypothyroidism

Nexium
    Administration route: Oral

Sintrom
    Dosage: dose:0.25 unit(s)
    Administration route: Oral
    Indication: Atrial Fibrillation

Esidrix
    Administration route: Oral

Lasix
    Administration route: Oral



Possible Esidrix side effects in male

Reported by a physician from Canada on 2012-03-02

Patient: male, weighing 61.8 kg (136.0 pounds)

Reactions: Cerebral Hypoperfusion, Hypotension, Vision Blurred

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Aliskiren
    Dosage: 150 mg, unk
    Indication: Cardiovascular Disorder
    Start date: 2011-10-01
    End date: 2011-11-09

Hydrochlorothiazide
    Dosage: 25 mg, unk
    End date: 2011-11-09

Amlodipine
    Dosage: 5 mg, unk
    Indication: Cardiovascular Disorder
    Start date: 2011-10-01
    End date: 2011-10-08

Valsartan
    Dosage: 160 mg, qd

Blinded Aliskiren
    Dosage: active run in phase
    Indication: Cardiovascular Disorder

Amlodipine
    Dosage: active run in phase
    Indication: Cardiovascular Disorder

Esidrix
    Dosage: active run in phase
    Indication: Cardiovascular Disorder

Placebo
    Dosage: active run in phase
    Indication: Cardiovascular Disorder

Blinded NO Treatment Received
    Dosage: active run in phase
    Indication: Cardiovascular Disorder

Other drugs received by patient: Atorvastatin Calcium; Aspirin



Possible Esidrix side effects in male

Reported by a physician from Canada on 2012-02-22

Patient: male, weighing 61.8 kg (136.0 pounds)

Reactions: Cerebral Hypoperfusion, Hypotension

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Blinded NO Treatment Received
    Dosage: active run in phase
    Indication: Cardiovascular Disorder

Blinded Aliskiren
    Dosage: active run in phase
    Indication: Cardiovascular Disorder

Valsartan
    Dosage: 160 mg, qd

Blinded Placebo
    Dosage: active run in phase
    Indication: Cardiovascular Disorder

Hydrochlorothiazide
    Dosage: 25 mg, unk

Amlodipine
    Dosage: active run in phase
    Indication: Cardiovascular Disorder

Amlodipine
    Dosage: 5 mg, unk
    Indication: Cardiovascular Disorder
    Start date: 2011-10-01
    End date: 2011-10-08

Esidrix
    Dosage: active run in phase
    Indication: Cardiovascular Disorder

Aliskiren
    Dosage: 150 mg, unk
    Indication: Cardiovascular Disorder
    Start date: 2011-10-01
    End date: 2011-11-08

Other drugs received by patient: Atorvastatin; Aspirin

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017